StonvexLoading…
StonvexStonvexStonvexCore line items from STM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $11.80B | $13.27B | $17.29B | $16.13B |
Operating Income | $175.00M | $1.68B | $4.61B | $4.44B |
Net Income | $166.00M | $1.56B | $4.21B | $3.96B |
EPS (Diluted) | $0.18 | $1.66 | $4.46 | $4.19 |
Total Assets | $24.80B | $24.74B | $24.45B | $19.98B |
Total Liabilities | $6.58B | $7.06B | $7.60B | $7.22B |
Cash & Equivalents | $2.84B | $2.28B | $3.22B | $3.26B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 888.77M | 898.18M | 902.77M | 903.87M |